<html>
<head>PUBMED IDs for COL5A3</head>
<body bgcolor='#C5F0F2'><h1>COL5A3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10722718/'>The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains.</a> March 18  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11992482/'>Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.</a> May 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15054833/'>Exclusion of candidate genes in a family with arterial tortuosity syndrome.</a> April 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316020/'>The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene (COL5A3).</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/19012342/'>Absence of apparent disease causing mutations in COL5A3 in 13 patients with hypermobility Ehlers-Danlos syndrome.</a> November 18  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/26396976/'>Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins.</a> September 24  2015<br></body></html>
